ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 184 out of 1121

$935K Total Retail Price of All Prescriptions

Rank: 93 out of 1121

469 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 10,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 756 493 S3 1 3
OMEPRAZOLE 393 317 2 6
AMLODIPINE BESYLATE 348 323 3 5
METOPROLOL SUCCINATE 312 289 4 23
SIMVASTATIN 302 251 5 1
PRAVASTATIN SODIUM 301 224 6 14
LEVOTHYROXINE SODIUM 271 254 7 2
METFORMIN HCL 236 161 8 8
FUROSEMIDE 234 189 9 7
LISINOPRIL 229 184 10 4
ATORVASTATIN CALCIUM 209 154 11 15
GABAPENTIN 156 87 12 13
POTASSIUM CHLORIDE 147 139 13 12
NEXIUM 147 106 13 24
TRAMADOL HCL 143 101 15 25
METFORMIN HCL ER 142 116 16 47
CARVEDILOL 141 135 17 20
METOPROLOL TARTRATE 134 111 18 9
BENAZEPRIL HCL 132 104 19 41
CYMBALTA 132 74 19 50
SERTRALINE HCL 128 86 21 21
ZOLPIDEM TARTRATE 126 100 22 19
DIOVAN HCT 118 95 23 90
PANTOPRAZOLE SODIUM 116 95 24 29
CRESTOR 116 96 24 28
TIZANIDINE HCL 113 68 26 124
SPIRIVA 108 78 27 49
SINGULAIR 105 88 28 78
BENAZEPRIL-HYDROCHLOROTHIAZIDE 105 87 28 153
VENLAFAXINE HCL ER 104 68 30 113
SYNTHROID 102 73 31 55
TAMSULOSIN HCL 101 91 32 32
ATENOLOL 100 75 33 16
LYRICA 97 66 34 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 93 89 35 31
OXYCODONE HCL 90 40 S2 36 68
LOSARTAN POTASSIUM 87 64 37 17
WARFARIN SODIUM 83 79 38 11
MELOXICAM 82 67 39 22
CELEBREX 81 68 40 104
ALENDRONATE SODIUM 81 63 40 37
BYSTOLIC 81 74 40 121
FENOFIBRATE 79 59 43 71
CLOPIDOGREL 79 72 43 27
PROAIR HFA 79 56 43 48
AMLODIPINE BESYLATE-BENAZEPRIL 79 63 43 65
JANUVIA 78 69 47 81
MIRTAZAPINE 75 73 48 56
GLIMEPIRIDE 73 55 49 34
PLAVIX 70 63 50 42
ISOSORBIDE MONONITRATE ER 69 62 51 62
PAROXETINE HCL 69 42 51 58
PRAMIPEXOLE DIHYDROCHLORIDE 68 46 53 158
DIOVAN 67 65 54 45
SYMBICORT 66 51 55 148
DONEPEZIL HCL 65 59 56 35
HYDROMORPHONE HCL 65 24 S2 56 284
RANITIDINE HCL 65 48 56 33
FLUOXETINE HCL 63 54 59 60
ENALAPRIL MALEATE 63 52 59 73
NAMENDA 62 56 61 53
LOSARTAN-HYDROCHLOROTHIAZIDE 61 60 62 46
FENTANYL 61 29 S2 62 100
PREMARIN 60 29 R 64 96
MONTELUKAST SODIUM 60 51 64 144
PROMETHAZINE HCL 60 17 R 64 67
LANTUS 60 37 64 52
HYDROCHLOROTHIAZIDE 59 37 68 10
CIPROFLOXACIN HCL 59 51 68 57
FLUCONAZOLE 59 24 68 156
CITALOPRAM HBR 58 46 71 18
ENDOCET 57 35 S2 72 107
FAMOTIDINE 57 43 72 63
AZITHROMYCIN 56 45 74 44
CYCLOBENZAPRINE HCL 56 19 R 74 83
OXYCODONE HCL-ACETAMINOPHEN 55 41 S2 76 86
ALLOPURINOL 55 55 76 30
LIPITOR 50 42 78 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.